Skip to main content
. 2022 Jul 30;14(8):1590. doi: 10.3390/pharmaceutics14081590

Figure 1.

Figure 1

Potential drug targets and repurposed drugs against glycolysis and sterol biosynthesis pathways of Leishmania parasite.